DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Levonorgestrel-releasing intrauterine system or hysterectomy in the treatment of essential menorrhagia: predictors of outcome.

Author(s): Hurskainen R, Teperi J, Aalto AM, Grenman S, Kivela A, Kujansuu E, Vuorma S, Yliskoski M, Rissanen P, Paavonen J

Affiliation(s): Departments of Obstetrics and Gynecology, University Hospitals of Helsinki, Finland. ritva.hurskainen@hus.fi

Publication date & source: 2004-04, Acta Obstet Gynecol Scand., 83(4):401-3.

Publication type: Clinical Trial; Randomized Controlled Trial

Levonorgestrel-releasing intrauterine system (LNG-IUS) has been advocated as an effective alternative to hysterectomy in the treatment of menorrhagia. The outcome predictors have been poorly known. In this study the amount of menstrual blood loss (MBL) turned out to be the single most important outcome predictor of these treatments. However, the treatment with LNG-IUS seemed to be an appropriate alternative to hysterectomy for all women who perceived their MBL heavy.

Page last updated: 2006-01-31

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017